4.1 Article

High-density lipoprotein proteome dynamics in human endotoxemia

期刊

PROTEOME SCIENCE
卷 9, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1477-5956-9-34

关键词

-

资金

  1. European Commission [LSHM-CT-2006-037631]
  2. GIGA (University of Liege)
  3. European Regional Development Fund

向作者/读者索取更多资源

Background: A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mass spectrometry (MS) was used to study the dynamic changes of HDL protein composition in a human experimental low-dose endotoxemia model. Ten healthy men with low HDL cholesterol (0.7+/-0.1 mmol/L) and 10 men with high HDL cholesterol levels (1.9+/-0.4 mmol/L) were challenged with endotoxin (LPS) intravenously (1 ng/kg bodyweight). We previously showed that subjects with low HDL cholesterol are more susceptible to an inflammatory challenge. The current study tested the hypothesis that this discrepancy may be related to differences in the HDL proteome. Results: Plasma drawn at 7 time-points over a 24 hour time period after LPS challenge was used for direct capture of HDL using antibodies against apolipoprotein A-I followed by subsequent SELDI-TOF MS profiling. Upon LPS administration, profound changes in 21 markers (adjusted p-value < 0.05) were observed in the proteome in both study groups. These changes were observed 1 hour after LPS infusion and sustained up to 24 hours, but unexpectedly were not different between the 2 study groups. Hierarchical clustering of the protein spectra at all time points of all individuals revealed 3 distinct clusters, which were largely independent of baseline HDL cholesterol levels but correlated with paraoxonase 1 activity. The acute phase protein serum amyloid A-1/2 (SAA-1/2) was clearly upregulated after LPS infusion in both groups and comprised both native and N-terminal truncated variants that were identified by two-dimensional gel electrophoresis and mass spectrometry. Individuals of one of the clusters were distinguished by a lower SAA-1/ 2 response after LPS challenge and a delayed time-response of the truncated variants. Conclusions: This study shows that the semi-quantitative differences in the HDL proteome as assessed by SELDI-TOF MS cannot explain why subjects with low HDL cholesterol are more susceptible to a challenge with LPS than those with high HDL cholesterol. Instead the results indicate that hierarchical clustering could be useful to predict HDL functionality in acute phase responses towards LPS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa

Anja Maag, Nienke van Rein, Tim J. Schuijt, Wil F. Kopatz, Danielle Kruijswijk, Stella Thomassen, Tilman M. Hackeng, Rodney M. Camire, Tom van der Poll, Joost C. M. Meijers, Mettine H. A. Bos, Cornelis van't Veer

Summary: Plasma thrombin generation provides important information on coagulation status, but current parameters do not predict major bleeding in patients on anticoagulants. Activation of factor V by factor Xa contributes significantly to thrombin generation, with greater activation associated with increased risk of major bleeding during VKA therapy.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

Marc V. A. van Moorsel, Geke C. Poolen, Cornelis A. Koekman, Sandra Verhoef, Steven de Maat, Arjan Barendrecht, Nadine D. van Kleef, Joost C. M. Meijers, Raymond M. Schiffelers, Coen Maas, Rolf T. Urbanus

Summary: We have developed a VhH anti-thrombomodulin (TM) clone 1 that inhibits TAFI activation and enhances tPA-mediated fibrinolysis under flow.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Correction Rheumatology

Coagulation in gout: is there a link with disease activity? (February, 10.1007/s10067-022-06047-9, 2022)

Daisy Vedder, Martijn Gerritsen, Joost C. M. Meijers, Michael T. Nurmohamed

CLINICAL RHEUMATOLOGY (2022)

Article Hematology

Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH

Nicola J. Mutch, Sam Walters, Elizabeth E. Gardiner, Owen J. T. McCarty, Simon F. De Meyer, Verena Schroeder, Joost C. M. Meijers

Summary: Bleeding and thrombosis are major clinical problems. Basic research in this field is facing funding challenges. The International Society on Thrombosis and Haemostasis (ISTH) established a task force to identify research opportunities and priorities in this area.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX?

Li Li, Mark Roest, Joost C. M. Meijers, Bas de Laat, Rolf T. Urbanus, Philip G. de Groot, Dana Huskens

Summary: Collagen activates platelets to initiate coagulation independently of certain clotting factors, and the activation of glycoprotein VI on platelets leads to the initiation of thrombin generation through platelet-derived FIXa activity.

THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

A FRET-based assay for the quantitation of the thrombin-factor XI interaction

Awital Bar Barroeta, J. Arnoud Marquart, Joost C. M. Meijers

Summary: A reliable assay was established to measure the binding between FXI and thrombin, which is suitable for high-throughput screening. The assay produces a stable signal that meets the sensitivity and robustness criteria for application in high-throughput screening. Moreover, it was possible to measure modulation of the interaction with non-labelled FXI.

THROMBOSIS RESEARCH (2022)

Article Hematology

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

Awital Bar Barroeta, J. Arnoud Marquart, Kamran Bakhtiari, Alexander B. Meijer, Rolf T. Urbanus, Joost C. M. Meijers

Summary: Background Factor XI (FXI) is a potential target for novel anticoagulants, and nanobodies have been developed to interfere with FXIa mediated activation of factor IX (FIX), thereby reducing the risk of thrombosis.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Biochemistry & Molecular Biology

Effect of N-3 Polyunsaturated Fatty Acids on Lipid Composition in Familial Hypercholesterolemia: A Randomized Crossover Trial

Liv Nesse Hande, Christian Kjellmo, Kristin Pettersen, Stefan Ljunggren, Helen Karlsson, Karin Cederbrant, Maritha Marcusson-Stahl, Anders Hovland, Knut Tore Lappegard

Summary: High-dose n-3 PUFAs supplements reduce atherogenic lipoproteins in FH subjects without affecting HDL-C function.

BIOMEDICINES (2022)

Article Engineering, Electrical & Electronic

Cyber-physical risk modeling with imperfect cyber-attackers

Efthymios Karangelos, Louis Wehenkel

Summary: We modeled the decision-making problem of a malicious cyber-attacker and analyzed the distribution of decisions and their respective impact when based on imperfect information. Our findings suggest that inaccurate data on grid branch admittances lead to suboptimal cyber-attacks, while inaccurate capacity values result in less effective attacks. Additionally, we identified common attacked cyber-assets and affected physical-assets, which can be used for effective cyber-physical risk management.

ELECTRIC POWER SYSTEMS RESEARCH (2022)

Article Hematology

How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey

Martine J. Hollestelle, Joost C. M. Meijers, Piet Meijer

Summary: The study aimed to gain insight into the approach of laboratories toward VWD diagnosis. Data from four samples of the external quality assessment (EQA) VWF surveys of the ECAT were evaluated, and results were analyzed of a questionnaire that was sent to hemostasis laboratories about VWD diagnostic approaches.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2022)

Article Hematology

How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey

Martine J. Hollestelle, Joost C. M. Meijers, Piet Meijer

Summary: The present study aimed to understand the approach of laboratories towards VWD diagnosis. Data from four samples of the external quality assessment (EQA) VWF surveys of the ECAT were evaluated, and the results of a questionnaire sent to hemostasis laboratories about VWD diagnostic approaches were analyzed.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2022)

Letter Hematology

The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis

Laure M. Fijen, Remy S. Petersen, Joost C. M. Meijers, Laura Bordone, Marcel Levi, Danny M. Cohn

THROMBOSIS AND HAEMOSTASIS (2022)

Article Engineering, Electrical & Electronic

A Methodology to Evaluate Reactive Power Reserves Scarcity During the Energy Transition

Elnaz Davoodi, Florin Capitanescu, Louis Wehenkel

Summary: This paper proposes a novel, generic, comprehensive, and realistic methodology to identify the severity of reactive power reserves scarcity during plausible scenarios of the energy transition. The proposed methodology can serve as a decision support tool for the transmission system operator (TSO), allowing them to assess different energy transition scenarios and inform about the timing of insufficient reactive power reserves.

IEEE TRANSACTIONS ON POWER SYSTEMS (2023)

Article Hematology

In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra

Herm Jan M. Brinkman, Marleen Zuurveld, Joost C. M. Meijers

Summary: This study aimed to compare the efficacy of andexanet alfa and two different 4F-PCCs in reversing FXaI anticoagulation. The results showed that andexanet alfa effectively corrected thrombin generation parameters, while 4F-PCC predominantly increased peak thrombin and endogenous thrombin potential.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro

Herm Jan M. Brinkman, Frauke Swieringa, Marleen Zuurveld, Alicia Veninga, Sanne L. N. Brouns, Johan W. M. Heemskerk, Joost C. M. Meijers

Summary: The study demonstrates the beneficial effect of combined use of PCC and FVC in reversing DOAC-induced coagulopathy by increasing thrombin generation, improving clot formation, enhancing clot strength and resistance to lysis.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

暂无数据